Cytos Biotechnology's IPO

Cytos Biotechnology raised a round of funding on October 29, 2002. Investors include Public.

Cytos Biotechnology (SWX:CYTN) is a Swiss company that specializes in the discovery, development, and commercialization of immunodrugs, which are intended for use in the prevention and treatment of ch…

Articles about Cytos Biotechnology's IPO: